- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
US Breast Cancer Cases Could Increase 50% by 2030
The total number of breast cancer cases in the United States is forecast to be 50% greater in 2030 than it was in 2011 driven mostly by a marked increase in cases of estrogen receptor-positive tumors.
The total number of breast cancer cases in the United States is forecast to be 50% greater in 2030 than it was in 2011, when invasive and in-situ or screening-detected cancers are counted together, and this increase is driven mostly by a marked increase in cases of estrogen receptor (ER)—positive tumors and in women older than 70 years, according to research presented at the American Association for Cancer Research Annual Meeting 2015, April 18-22.
“Managing this clinical burden will present a huge challenge,” said Philip S. Rosenberg, PhD, a senior investigator in the division of cancer epidemiology and genetics at the National Cancer Institute. “The one silver lining is that we expect fewer ER—negative tumors, which include the most difficult-to-treat HER2-positive and triple-negative subtypes.”
Read the press release: http://bit.ly/1DJKoEu
How FcRn Blockade Targets Myasthenia Gravis Autoantibodies
January 29th 2025In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent in treating adolescents who have the myasthenia gravis and how nipocalimab works via FcRn blockade to reduce the circulating autoantibodies that drive myasthenia gravis.
Read More
